By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – NanoMR, a company developing diagnostics for the identification of pathogens, today announced it has raised $13 million in a Series B financing round.

The money will be used to develop commercial instruments for the clinical microbiology market, conduct clinical studies, and prepare for a product launch, the Albuquerque, NM-based firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.